Assembly Actions - Lowercase Senate Actions - UPPERCASE |
|
---|---|
Dec 31, 2019 | signed chap.748 |
Dec 19, 2019 | delivered to governor |
Jun 03, 2019 | returned to assembly passed senate 3rd reading cal.1142 substituted for s4808 |
Apr 10, 2019 | referred to insurance delivered to senate passed assembly |
Mar 21, 2019 | advanced to third reading cal.152 |
Mar 18, 2019 | reported |
Mar 12, 2019 | reported referred to codes |
Jan 28, 2019 | referred to insurance |
assembly Bill A2904
Signed By GovernorSponsored By
QUART
Archive: Last Bill Status - Signed by Governor
- Introduced
- In Committee
- On Floor Calendar
- Passed Senate
- Passed Assembly
- Delivered to Governor
- Signed by Governor
Your Voice
Actions
Votes
Co-Sponsors
David Weprin
Robert C. Carroll
Diana Richardson
Multi-Sponsors
Chris Tague
A2904 (ACTIVE) - Details
A2904 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 2904 2019-2020 Regular Sessions I N A S S E M B L Y January 28, 2019 ___________ Introduced by M. of A. QUART -- read once and referred to the Committee on Insurance AN ACT to amend the insurance law, in relation to prohibiting certain insurance policies from requiring prior authorization for certain medications used in the treatment of substance use disorders; and to repeal certain provisions of such law relating thereto THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Paragraph 31-a of subsection (i) of section 3216 of the insurance law is REPEALED and a new paragraph 31-a is added to read as follows: (31-A) (A) NO POLICY THAT PROVIDES MEDICAL, MAJOR MEDICAL OR SIMILAR COMPREHENSIVE-TYPE COVERAGE AND PROVIDES COVERAGE FOR PRESCRIPTION DRUGS FOR MEDICATION FOR THE TREATMENT OF A SUBSTANCE USE DISORDER SHALL REQUIRE PRIOR AUTHORIZATION FOR AN INITIAL OR RENEWAL PRESCRIPTION FOR ALL BUPRENORPHINE PRODUCTS, METHADONE OR LONG ACTING INJECTABLE NALTREX- ONE FOR DETOXIFICATION OR MAINTENANCE TREATMENT OF A SUBSTANCE USE DISORDER EXCEPT WHERE OTHERWISE PROHIBITED BY LAW. (B) COVERAGE PROVIDED UNDER THIS PARAGRAPH MAY BE SUBJECT TO COPAY- MENTS, COINSURANCE, AND ANNUAL DEDUCTIBLES THAT ARE CONSISTENT WITH THOSE IMPOSED ON OTHER BENEFITS WITHIN THE POLICY. § 2. Paragraphs 7-a and 7-b of subsection (l) of section 3221 of the insurance law are REPEALED and a new paragraph 7-a is added to read as follows: (7-A) (A) EVERY POLICY THAT PROVIDES MEDICAL, MAJOR MEDICAL OR SIMILAR COMPREHENSIVE-TYPE LARGE GROUP COVERAGE SHALL PROVIDE IMMEDIATE COVERAGE FOR ALL BUPRENORPHINE PRODUCTS, METHADONE OR LONG ACTING INJECTABLE NALTREXONE WITHOUT PRIOR AUTHORIZATION FOR THE DETOXIFICATION OR MAINTE- NANCE TREATMENT OF A SUBSTANCE USE DISORDER. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD01428-01-9